Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alessio Aghemo

Showing results (71-80 of 318) with videos related to

Pageof 32
Sort By:
Clinics and Research in Hepatology and Gastroenterology|March 26, 2011
Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis?Elena Vezali, Alessio Aghemo, Pietro Lampertico, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2018
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antiviralsVincenzo Craviotto, Laura Lamonaca, Alessio Aghemo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 6, 2022
No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single-centre in MilanChiara Masetti, Francesca Colapietro, Antonio Voza, et al.
Journal of Autoimmunity|March 14, 2019
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicineLorenza Rimassa, Nicola Personeni, Alessio Aghemo, et al.
Current Opinion in Virology|April 19, 2017
Direct-acting antivirals: the endgame for hepatitis C?Roberta D'Ambrosio, Elisabetta Degasperi, Massimo Colombo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 7, 2020
COVID-19 and liver diseaseJian Sun, Alessio Aghemo, Alejandro Forner, et al.
Viruses|October 14, 2011
HBV and HCV therapyPietro Lampertico, Alessio Aghemo, Mauro Viganò, et al.
The Lancet. Gastroenterology & Hepatology|December 12, 2018
Direct-acting antivirals for chronic hepatitis C virus genotype 5 and 6 infectionsMaria Corina Plaz Torres, Ana Lleo, Alessio Aghemo
Techniques and Innovations in Gastrointestinal Endoscopy|February 1, 2021
Stay (GI) Healthy: COVID-19 and Gastrointestinal ManifestationsEdoardo Vespa, Nicola Pugliese, Francesca Colapietro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 20, 2019
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing CholangitisGiulia Roda, Ana Lleo, Silvio Danese, et al.
Pageof 32

Showing results (71-80 of 318) with videos related to

Sort By:
Pageof 32
Clinics and Research in Hepatology and Gastroenterology|March 26, 2011
Does interferon therapy prevent hepatocellular carcinoma in patients with chronic viral hepatitis?Elena Vezali, Alessio Aghemo, Pietro Lampertico, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 16, 2018
No clinical impact of HCV RNA determination at the end of treatment in patients receiving directly acting antiviralsVincenzo Craviotto, Laura Lamonaca, Alessio Aghemo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 6, 2022
No impact of COVID-19 epidemic on decompensation of alcoholic liver disease: Results from a single-centre in MilanChiara Masetti, Francesca Colapietro, Antonio Voza, et al.
Journal of Autoimmunity|March 14, 2019
The immune milieu of cholangiocarcinoma: From molecular pathogenesis to precision medicineLorenza Rimassa, Nicola Personeni, Alessio Aghemo, et al.
Current Opinion in Virology|April 19, 2017
Direct-acting antivirals: the endgame for hepatitis C?Roberta D'Ambrosio, Elisabetta Degasperi, Massimo Colombo, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 7, 2020
COVID-19 and liver diseaseJian Sun, Alessio Aghemo, Alejandro Forner, et al.
Viruses|October 14, 2011
HBV and HCV therapyPietro Lampertico, Alessio Aghemo, Mauro Viganò, et al.
The Lancet. Gastroenterology & Hepatology|December 12, 2018
Direct-acting antivirals for chronic hepatitis C virus genotype 5 and 6 infectionsMaria Corina Plaz Torres, Ana Lleo, Alessio Aghemo
Techniques and Innovations in Gastrointestinal Endoscopy|February 1, 2021
Stay (GI) Healthy: COVID-19 and Gastrointestinal ManifestationsEdoardo Vespa, Nicola Pugliese, Francesca Colapietro, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 20, 2019
All That Glitters is Not Gold in Vedolizumab Therapy for Patients With Inflammatory Bowel Diseases and Primary Sclerosing CholangitisGiulia Roda, Ana Lleo, Silvio Danese, et al.
Pageof 32